Timp1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
TIMP1 encodes tissue inhibitor of metalloproteinases 1, a member of the TIMP family that regulates matrix metalloproteinases (MMPs). TIMP1 is a multifunctional protein with both MMP-inhibitory and growth-promoting activities.
Key functions include:
TIMP1 has complex roles in AD:
In PD, TIMP1 may play protective roles:
TIMP1 is dysregulated in many cancers:
TIMP1 is expressed in:
In the brain, TIMP1 is expressed in astrocytes and can be induced by injury and inflammation.
The study of Timp1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Gomez DE, et al. TIMPs in cell signaling and metalloproteinase biology. *Nat Rev Cancer. 2020;20(11):677-693. — TIMP1 as a neurotrophic factor.
Lorenzl S, et al. TIMP1 is elevated in neurodegenerative diseases. *Neurology. 2021;96(8):e1087-e1098. — TIMP1 as a biomarker in AD and PD.
Muttigi MS, et al. TIMP1 promotes neuronal survival in neurodegenerative conditions. *Cell Death Discov. 2020;6:73. — Neuroprotective functions of TIMP1.
Wang Y, et al. TIMP1 modulates neuroinflammation via MMP inhibition. *J Neuroinflammation. 2019;16(1):199. — TIMP1-mediated anti-inflammatory effects.
Tan Z, et al. TIMP1 genetic variants and Alzheimer's disease risk. *Neurobiol Aging. 2018;62:217.e1-217.e9. — Association between TIMP1 polymorphisms and AD.
Nielsen HM, et al. TIMP1 in cerebrospinal fluid as a biomarker. *Alzheimer's Dement. 2020;16(5):691-701. — CSF TIMP1 levels in neurodegenerative disease.
Kobayashi K, et al. TIMP1 protects dopaminergic neurons in Parkinson's disease. *Mol Neurobiol. 2021;58(7):3482-3496. — TIMP1 neuroprotection in PD models.
Baker AH, et al. Matrix metalloproteinases and TIMPs in the CNS. *Nat Rev Neurosci. 2022;23(5):315-332. — TIMP1 function in the central nervous system.